News

Minaris Regenerative Medicine is proud to share current and past news and announcements from its over twenty years of experience. Please see below for our press releases and announcements.

Global Media Contact
Almut Windhager, Ph.D.
press@rm.minaris.de

*This page may include mention of our past company names as it reflects content distributed in the past. The former companies Hitachi Chemical Advanced Therapeutics Solutions (HCATS, fomerly PCT or PCT Cell Therapy Services), apceth Biopharma GmbH, and Hitachi Chemical Co., Ltd. have been renamed Minaris Regenerative Medicine and are part of the Resonac Group.

October 2, 2024

Minaris Regenerative Medicine and TFBS Announce Strategic Partnership to Advance Cell and Gene Therapy

Allendale, NJ, USA and Taipei, Taiwan – October 2, 2024 Minaris Regenerative Medicine, LLC (Minaris) and TFBS Bioscience Inc. (TFBS) are pleased to announce a strategic partnership in cell and gene therapy (CGT) mainly in North America. This collaboration is designed to enhance their capabilities to drive industry innovation by providing the one-stop-shop solutions. The strategic partnership ...

All Posts

Minaris Regenerative Medicine and TFBS Announce Strategic Partnership to Advance Cell and Gene Therapy

Subscribe to Our Email Distribution List